This topic contains a solution. Click here to go to the answer

Author Question: A nurse is teaching a patient about the possible adverse effects of oral contraceptives. The nurse ... (Read 64 times)

maychende

  • Hero Member
  • *****
  • Posts: 556
A nurse is teaching a patient about the possible adverse effects of oral contraceptives. The nurse evaluates that the patient understands this teaching if which statement is made?
 
  1. I may experience increased acne while on oral contraceptives.
  2. If I experience chest pain, I will call the clinic immediately.
  3. If I begin to lose more hair than is normal, my dose may need to be adjusted.
  4. Any blurry vision or loss of vision should be reported immediately.
  5. If I notice swelling in my feet, hands, or face, I will notify the clinic.

Question 2

The nurse administers an IM dose of risperidone (Risperdal) to a client. How long until the nurse will need to administer another dose?
 
  1. 1 day
  2. 3 weeks
  3. 46 weeks
  4. 12 weeks



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cuttiesgirl16

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

1,2,4,5
Rationale 1: Oral contraceptive use may result in an increase in acne.
Rationale 2: Chest pain is a serious symptom and should be reported.
Rationale 3: Hirsutism, not hair loss, may occur as an adverse effect of oral contraceptive use.
Rationale 4: Blurry vision can be associated with glucose elevation, hypertension, or other adverse effects of oral contraceptive use.
Rationale 5: Edema is a common effect of oral contraceptive use.
Global Rationale: Oral contraceptive use may result in an increase in acne. Chest pain is a serious symptom and should be reported. Blurry vision can be associated with glucose elevation, hypertension, or other adverse effects of oral contraceptive use. Edema is a common effect of oral contraceptive use. Hirsutism, not hair loss, may occur as an adverse effect of oral contraceptive use.

Answer to Question 2

3

Rationale 1: Risperdal has a small amount of drug released in 1 day and the rest after 3 weeks, and lasts 46 weeks.
Rationale 2: Risperdal has a small amount of drug released in 1 day and the rest after 3 weeks, and lasts 46 weeks.
Rationale 3: Risperdal has a small amount of drug released in 1 day and the rest after 3 weeks, and lasts 46 weeks.
Rationale 4: This is the amount of time for the onset of oral Risperdal.

Global Rationale: Risperdal has a small amount of drug released in 1 day and the rest after 3 weeks, and lasts 46 weeks. All the other answer choices are incorrect.




maychende

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
:D TYSM


Liddy

  • Member
  • Posts: 342
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

For a complete list of videos, visit our video library